Clinical Trials Directory

Trials / Completed

CompletedNCT00689013

The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
205 (actual)
Sponsor
University of Tennessee · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether pharmacist-driven patient interventions can have an effect on the number of herpes zoster (Zostavax) vaccinations given in a community pharmacy setting.

Detailed description

Several studies exist documenting the perception and satisfaction of patients receiving immunizations from pharmacists, as well as the effects of pharmacist involvement in advocating and administering vaccinations. The most well documented studies have been conducted in hospital settings. Undoubtedly, there is enormous opportunity for the community pharmacist to identify potential vaccine recipients, advocate immunization and administer said immunizations to their established patient populations. However, there is a lack of concentrated study in the implementation of immunization services in the community setting and their effects. The investigators intend to evaluate the intervention of pharmacists in an immunization program and the resulting changes in immunization rates.

Conditions

Interventions

TypeNameDescription
OTHERPersonalized letterOn Day 1 of the 2nd month, a personalized letter (addressing specific patient) was mailed to current pharmacy patients with indications for the Zostavax vaccine. Current patients were defined as those receiving at least one prescription medication from the pharmacy within 6 months. The personalized letter provided detailed information about herpes zoster infection, the vaccine for herpes zoster prevention, indications for vaccine receipt and contraindications for vaccine receipt.
OTHERFlyer advertisementBeginning on Day 1 of the 2nd month, flyer advertisements were distributed with all pharmacy sales. Flyer advertisements provided detailed information about herpes zoster infection, the vaccine for herpes zoster prevention, indications for vaccine receipt and contraindications for vaccine receipt.
OTHERNewspaper press releaseDuring the first week of the 2nd month, local newspapers published press releases. The press release provided detailed information about herpes zoster infection, the vaccine for herpes zoster prevention, indications for vaccine receipt and contraindications for vaccine receipt.

Timeline

Start date
2008-02-01
Primary completion
2008-03-01
Completion
2008-03-01
First posted
2008-06-03
Last updated
2009-04-23

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00689013. Inclusion in this directory is not an endorsement.